Noninvasive Markers of Hepatic Fibrosis in Chronic Hepatitis B.
about
Factors That Could Impact on Liver Fibrosis Staging by Transient ElastographyTransient Elastography for Assessment of Liver Fibrosis and Steatosis: An Evidence-Based Analysis.Systematic review with meta-analysis: direct comparisons of biomarkers for the diagnosis of fibrosis in chronic hepatitis C and BNon-invasive diagnosis of liver fibrosis and cirrhosis.Clinical Application of Transient Elastography in the Diagnosis of Liver Fibrosis: an Expert Panel Review and OpinionNon-invasive prediction of forthcoming cirrhosis-related complications.Non-invasive assessment of liver fibrosis in chronic hepatitis B.Development of a non-invasive fibrosis test for chronic hepatitis B patients and comparison with other unpatented scores.FibroSURE as a noninvasive marker of liver fibrosis and inflammation in chronic hepatitis BPerformance of Enhanced Liver Fibrosis test and comparison with transient elastography in the identification of liver fibrosis in patients with chronic hepatitis B infection.A novel non-invasive index using AFP and APTT is associated with liver fibrosis in patients with chronic hepatitis B infection: a retrospective cohort studyEvaluating the Significance of Viscoelasticity in Diagnosing Early-Stage Liver Fibrosis with Transient Elastography.Noninvasive assessment of liver damage in chronic hepatitis B.Consensus on biomarkers for neuroendocrine tumour diseasePrediction of fibrosis in hepatitis C patients: assessment using hydroxyproline and oxidative stress biomarkers.Hepatic inflammation and progressive liver fibrosis in chronic liver disease.Long-term therapy for chronic hepatitis B: hepatitis B virus DNA suppression leading to cirrhosis reversal.Review article: The prevention and reversal of hepatic fibrosis in autoimmune hepatitis.FibroTest/Fibrosure for significant liver fibrosis and cirrhosis in chronic hepatitis B: a meta-analysis.Prognostic value of the combined use of transient elastography and fibrotest in patients with chronic hepatitis B.Targeting Hepatic Fibrosis in Autoimmune Hepatitis.Dynamic Changes in Liver Stiffness Measured by Transient Elastography Predict Clinical Outcomes Among Patients With Chronic Hepatitis B.Prognostic value of liver fibrosis biomarkers: a meta-analysis.Non-invasive assessment of liver fibrosis in patients with chronic hepatitis B.Improvement of liver function and non-invasive fibrosis markers in hepatitis B virus-associated cirrhosis: 2 years of entecavir treatment.Metabolic syndrome association with fibrosis development in chronic hepatitis B virus inactive carriers.Differences in liver fibrosis between patients with chronic hepatitis B and C: evaluation by acoustic radiation force impulse measurements at 2 locations.Non-invasive tests for fibrosis and liver stiffness predict 5-year survival of patients chronically infected with hepatitis B virus.Controlled attenuation parameter for non-invasive assessment of hepatic steatosis: does etiology affect performance?
P2860
Q26771788-73FF8FB0-AB01-473C-819F-60C9A00A5F55Q26776180-F1D5B426-1D3D-44AC-BA9C-AF44C28CE8F5Q26777916-12923972-5103-451B-A936-508F9498381CQ26778033-E4D1B2B7-0EC3-4370-A047-0BE27EADA4A8Q26852557-EC9DECC5-54B5-4280-918A-226C0BDB6806Q27000645-E71C6B7D-52D0-4A13-B086-7D9E80C2B052Q30427489-A05CA1BC-CBF2-4ECA-AA71-56F1B0E5DC1FQ30453789-4763CADF-E053-4078-AA41-66E7D7B889E7Q31170758-7EAE412F-41A6-485F-8F9B-B6F38C85BC75Q34981143-671112A4-29B9-4097-9728-D42B24EA6BC2Q36080925-206B8D93-2758-4A8D-979B-799CCB86850AQ36255455-1D8ECB3A-C575-42CE-B4A8-4E6732E5CA17Q37157860-4FE49216-0C38-4B1E-961D-5DA0A76A971AQ37255681-6289E127-734D-4845-8E20-7FADA2CBAF26Q37468027-CA7DEDEC-04DA-43A6-9D94-FFC74E680918Q37629675-873BB3F5-DF2E-46CF-BC88-B20A27AC62B3Q38097858-0B4FEACA-89B2-4C9B-A548-4919ECA2D123Q38175465-0C75EC41-C33D-4984-9506-734F3637043BQ38188809-ADDFC5FB-CEDB-4DD1-92A8-E2EE3F2B8686Q38434496-42A325E9-EC1E-458E-AF2D-4E7ABB7F5E49Q38902371-B6A54B35-6C9E-4949-A7CD-F46D4E59202DQ39134237-2331D21A-3CCE-4AD4-9555-97CB293E802FQ40621139-61928752-B0CE-456F-ADE8-A38A9D00A946Q40707349-E4F634B7-3306-42D4-8B61-90C7971DED72Q41653263-91461FFD-9D16-4E03-82B7-628C4636307DQ42256245-9E697CF4-C687-4346-966A-370F521FDF2AQ42695439-62D1B2BB-AA70-46A2-A776-9CF79832F669Q43419593-8572A7EE-6B6A-4A5D-91AD-8D68978A5118Q45206614-21F77A5F-3F5D-42CC-8C7D-72EFF878A350
P2860
Noninvasive Markers of Hepatic Fibrosis in Chronic Hepatitis B.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Noninvasive Markers of Hepatic Fibrosis in Chronic Hepatitis B.
@ast
Noninvasive Markers of Hepatic Fibrosis in Chronic Hepatitis B.
@en
Noninvasive Markers of Hepatic Fibrosis in Chronic Hepatitis B.
@nl
type
label
Noninvasive Markers of Hepatic Fibrosis in Chronic Hepatitis B.
@ast
Noninvasive Markers of Hepatic Fibrosis in Chronic Hepatitis B.
@en
Noninvasive Markers of Hepatic Fibrosis in Chronic Hepatitis B.
@nl
prefLabel
Noninvasive Markers of Hepatic Fibrosis in Chronic Hepatitis B.
@ast
Noninvasive Markers of Hepatic Fibrosis in Chronic Hepatitis B.
@en
Noninvasive Markers of Hepatic Fibrosis in Chronic Hepatitis B.
@nl
P2093
P2860
P1476
Noninvasive Markers of Hepatic Fibrosis in Chronic Hepatitis B.
@en
P2093
Dominique Thabut
Vlad Ratziu
P2860
P356
10.1007/S11901-011-0096-0
P577
2011-03-01T00:00:00Z